These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1617450)

  • 1. Iron induces degeneration of nigrostriatal neurons.
    Sengstock GJ; Olanow CW; Dunn AJ; Arendash GW
    Brain Res Bull; 1992 Apr; 28(4):645-9. PubMed ID: 1617450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.
    Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW
    J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra.
    Sengstock GJ; Olanow CW; Dunn AJ; Barone S; Arendash GW
    Exp Neurol; 1994 Nov; 130(1):82-94. PubMed ID: 7529713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study.
    Oestreicher E; Sengstock GJ; Riederer P; Olanow CW; Dunn AJ; Arendash GW
    Brain Res; 1994 Oct; 660(1):8-18. PubMed ID: 7828004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurine infused intrastriatally elevates, but intranigrally decreases striatal extracellular dopamine concentration in anaesthetised rats.
    Ruotsalainen M; Heikkilä M; Lillsunde P; Seppälä T; Ahtee L
    J Neural Transm (Vienna); 1996; 103(8-9):935-46. PubMed ID: 9013387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.
    Ben-Shachar D; Eshel G; Finberg JP; Youdim MB
    J Neurochem; 1991 Apr; 56(4):1441-4. PubMed ID: 1900527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats.
    Ben-Shachar D; Youdim MB
    J Neurochem; 1991 Dec; 57(6):2133-5. PubMed ID: 1940919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolism.
    Wesemann W; Solbach M; Nafe R; Grote C; Sontag KH; Riederer P; Jellinger K; Mennel HD; Clement HW
    J Neural Transm Suppl; 1995; 46():175-82. PubMed ID: 8821053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
    Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
    Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranigral iron infusion in the rat. Acute elevations in nigral lipid peroxidation and striatal dopaminergic markers with ensuing nigral degeneration.
    Sengstock GJ; Zawia NH; Olanow CW; Dunn AJ; Arendash GW
    Biol Trace Elem Res; 1997 Sep; 58(3):177-95. PubMed ID: 9403131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
    Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.